Does Restriction of the Dominant Hand Due to Injury Improve Non-Dominant Hand Function?

March 2, 2026 updated by: Sedanur Güngör, Gazi University
Hand injuries result in the restriction of use of the injured hand within a splint or a plaster during the first 6 weeks which is critical for tissue healing. When the dominant hand is injured, patients experience more difficulty in daily life due to this restriction. Patients injured on their dominant hand mostly express that they are forced to use their non-dominant hand in their activities and as a result, the function of the non-dominant hand improves. However, the non-dominant hand function has not been analyzed in patients with restricted use of the dominant hand during the tissue healing period.

Study Overview

Study Type

Observational

Enrollment (Actual)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Yenimahalle
      • Ankara, Yenimahalle, Turkey (Türkiye)
        • Gazi University Health Science Faculty Physiotherapy and Rehabilitation Department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients referred to the Hand Rehabilitation Unit of Gazi University, Faculty of Health Sciences, for physiotherapy and rehabilitation due to hand-related pathologies, and who meet the inclusion and exclusion criteria will be included.

Description

Inclusion Criteria:

  • Individuals who need to use a splint for 6 weeks due to any pathology in their dominant hand
  • Ages between 18-65
  • Individuals who are within the first 10 days after the operation

Exclusion Criteria:

  • Individuals with an isolated thumb injury
  • Those who require bilateral use of the splint/have bilateral pathology
  • Those who have a condition that prevents the use of the non-dominant hand
  • Those who can use both hands equally/do not have a dominant side (ambidextrous/two-handed)
  • Those who have a cooperative status that will not comply with the treatment program
  • Data from individuals who do not use the splint as described during the 6-week follow-up period will not be included in the analysis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
patient with orthosis/cast
Patients referred to the Hand Rehabilitation Unit of Gazi University, Faculty of Health Sciences, for physiotherapy and rehabilitation due to hand-related pathologies, and who meet the inclusion and exclusion criteria, will be informed about the study. No treatment other than routine care will be administered. Only two evaluations will be conducted: one at the first session and the other at the end of the 6th week.
This study aimed to assess whether the non-dominant hand function changes in patients using splints or casts on their dominant hand during the tissue healing period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
hand function
Time Frame: 6 weeks
Hand function will be assessed using the Jebsen Taylor Hand Function Test (JTHFT), a valid tool for evaluating impairment and disability. The test includes tasks involving common grip types in daily life, aiming to measure the speed of task performance. Standardized materials, easily available in clinics, are used. The test has seven tasks: writing a 24-letter text, turning cards, collecting small objects, eating, stacking checkers, collecting light wide objects, and collecting heavy wide objects. A 1-minute rest is given between tasks, and completion time is recorded in seconds. Before evaluation, examples will be provided, and individuals will perform a trial run of each task. In our study, only the unaffected, non-dominant hand will be assessed, starting with a single real assessment after the trial.
6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
disability level
Time Frame: 6 weeks
Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire will be measured. This questionnaire is used to assess upper extremity disorders and includes 30 items covering pain, stiffness, weakness, daily activities, and functionality. Patients consider their condition over the past week, with total scores ranging from 0 to 100. Higher scores indicate worse functional status.
6 weeks
Grip and pinch strengths
Time Frame: 6 weeks
Gross grip strength will be measured with a hydraulic hand dynamometer (Jamar®) and fine grip strength with a pinchmeter. Participants will sit in a chair with back support, following the standard position: arm at the side, elbow at 90° flexion, and wrist neutral. Fine grip strength will be assessed in double (bipod) pinch, triple (tripod) pinch, and lateral grip positions. The forearm will be fully pronated for double and triple pinches, and midpronated for gross grip and lateral grips. Only the healthy non-dominant hand will be assessed. Measurements will be repeated three times, and participants will squeeze as hard as possible. The average of the three trials will be recorded in kilograms.
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 6, 2024

Primary Completion (Actual)

March 1, 2026

Study Completion (Actual)

March 1, 2026

Study Registration Dates

First Submitted

January 13, 2025

First Submitted That Met QC Criteria

January 14, 2025

First Posted (Actual)

January 20, 2025

Study Record Updates

Last Update Posted (Actual)

March 4, 2026

Last Update Submitted That Met QC Criteria

March 2, 2026

Last Verified

March 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2024-390

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tendon Injuries

Clinical Trials on Restriction of the Dominant Hand Due to Splint Use

Subscribe